Related Experiment Videos
LRP and Alzheimer's disease
Celina V Zerbinatti1, Guojun Bu
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Reviews in the Neurosciences
|June 18, 2005
Summary
The low-density lipoprotein receptor (LDLR)-related protein (LRP) is crucial for development and brain function. LRP influences Alzheimer's disease (AD) by affecting amyloid precursor protein (APP) and amyloid-beta (Abeta) metabolism.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- The low-density lipoprotein receptor (LDLR)-related protein (LRP) is a large transmembrane endocytic receptor.
- LRP plays essential roles in development, as indicated by embryonic lethality in knockout mice.
- LRP is highly expressed in the central nervous system (CNS), particularly in neurons.
Purpose of the Study:
- To review the role of LRP in the central nervous system (CNS).
- To discuss the potential mechanisms by which LRP influences Alzheimer's disease (AD) pathogenesis.
- To explore LRP's involvement in amyloid precursor protein (APP) and amyloid-beta (Abeta) metabolism.
Main Methods:
- Literature review of studies on LRP function.
- Analysis of LRP's interactions with key molecules in AD.
- Examination of genetic evidence linking LRP to AD.
Main Results:
- LRP mediates neurite outgrowth stimulated by apolipoprotein E (apoE).
- ApoE4 allele carriers have an increased risk of AD.
- LRP binds to APP and Abeta, both implicated in AD pathogenesis.
Conclusions:
- LRP is a significant factor in brain development and function.
- LRP's interaction with APP and Abeta suggests a role in Alzheimer's disease (AD) pathogenesis.
- Further research into LRP mechanisms could reveal new therapeutic targets for AD.